These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15682547)

  • 21. Innovative insulins--where do analogues fit?
    Phillips LK; Phillips PJ
    Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin therapy components.
    Moses A
    Am Fam Physician; 2004 Dec; 70(11):2081. PubMed ID: 15606055
    [No Abstract]   [Full Text] [Related]  

  • 23. Conventional therapy with insulin.
    Nattrass M
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):13-6. PubMed ID: 19667600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Was insulin review biased, or simply a victim of bad timing?
    Brunton S
    J Fam Pract; 2007 May; 56(5):E1-4; author reply E1-4. PubMed ID: 17475156
    [No Abstract]   [Full Text] [Related]  

  • 25. Was insulin review biased, or simply a victim of bad timing?
    Heise T
    J Fam Pract; 2007 May; 56(5):E1-4; author reply E1-4. PubMed ID: 17611994
    [No Abstract]   [Full Text] [Related]  

  • 26. [Short acting insulin analogues for type 2 diabetes. Unnecessary additional expenditure or valuable added benefit? Interview by Böhm Sanja].
    Hess R; Kerner W
    Dtsch Med Wochenschr; 2006 Oct; Suppl 1():36-7. PubMed ID: 17595817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Are the short-acting insulin analogs superfluous?].
    Arand M
    MMW Fortschr Med; 2006 Mar; 148(11):17. PubMed ID: 16612957
    [No Abstract]   [Full Text] [Related]  

  • 28. Post-marketing studies of new insulins: sales or science?
    Gale EA
    BMJ; 2012 Jun; 344():e3974. PubMed ID: 22692652
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update in diabetes management.
    Cranwell-Bruce LA
    Medsurg Nurs; 2009; 18(1):51-3; quiz 54. PubMed ID: 19331300
    [No Abstract]   [Full Text] [Related]  

  • 31. The nature of type 2 diabetes: the role for new agents.
    Taylor R
    Int J Clin Pract Suppl; 1999 Jul; 104():14-7; discussion 18-20. PubMed ID: 12669733
    [No Abstract]   [Full Text] [Related]  

  • 32. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new insulins.
    Crotty S; Reynolds SL
    Pediatr Emerg Care; 2007 Dec; 23(12):903-5; quiz 906-7. PubMed ID: 18091602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
    Gong WC
    Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The new insulins].
    Krzentowski G
    Rev Med Brux; 2005 Sep; 26(4):S241-5. PubMed ID: 16240869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin in type 2 diabetes: promises to keep.
    Basu AK; Bandyopadhyay D; Bandyopadhyay R; Majumdar D; Chakrabarty PP
    J Indian Med Assoc; 2004 Aug; 102(8):438, 440, 442 passim. PubMed ID: 15719806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimal therapeutic strategy in type 2 diabetes mellitus].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.
    Janka HU
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():35-41. PubMed ID: 18577155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.